SHINE JUSTICE LTD — Director's Dealing 2022

Aug 31, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Shine Justice Ltd

ABN 93 162 817 905

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	David Sutton Bayes
Date of last notice	1 July 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Change from direct to indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.	Fully paid ordinary shares acquired by PacificCustodians Pty Limited as trustee for the Non-executive Director Equity Plan (NED Equity Plan)(Trustee)
Date of change	31 August 2022
No. of securities held prior to change	Direct: 27,408 FY22 NED Rights27,731 FY23 NED RightsIndirect: 31,104 fully paid ordinary shares (Kateco(Vic.) Pty Ltd as trustee for the DavidBayes Investment Trust) (Kateco)14,884fullypaidordinaryshares(Trustee)
Class	Fully paid ordinary shares
Number acquired	27,408
Number disposed	Nil

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration	In accordance with the NED Equity Plan, Mr Bayes
Note: If consideration is non-cash, provide details andestimated valuation	salary sacrificed an amount of $26,400 during theperiod 1 July 2021 to 30 June 2022. The number of
	FY22 NED Rights granted to Mr Bayes was based
	on the amount of director fees and superannuation
	agreed to be sacrificed during that period, divided
	by the volume weighted average price of Shine
	Justice Ltd shares on ASX for the 15 trading days
	before and the 15 trading days after the date of the
	relevant invitation to participate in the NED Equity
	Plan ($0.96).
No. of securities held after change	Direct:27,731 FY23 NED Rights
	Indirect:31,104 fully paid ordinary shares
	(Kateco)
	42,292 fully paid ordinary shares
	(Trustee)
Nature of change	Allocation of 27,408 fully paid ordinary shares
Example: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestmentplan, participation in buy-back	(acquired by the Trustee on market) on vesting of27,408 FY22 NED Rights

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in relation to
which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3